We’re Stronger Together
With your help, we can advance education and improve student success in our community.
Research Projects & Grants
For Profit Organization
- Psychometric validation of the pediatric gastroesophageal reflux disease (GERD) symptom and quality of life questionnaire (PGSQ), Role: PI, TAP Pharmaceuticals, Inc,, (04/2007 - 04/2008) Status: Completed
- Lansoprazole study C03-042: A Phase I, single-and repeated-dose, randomized, open-label, multicenter study to evaluate the pharmacokinetics, pharmacodynamics and safety of lansoprazole in neonates with clinically-evident gastroesophageal reflux disease, Role: Investigator, TAP Pharmaceuticals, Inc,, (03/2005 - 03/2006) Status: Completed
- Lansoprazole study C03-043: A Phase I, single- and repeated-dose, randomized, open-label, multicenter study to evaluate the pharmacokinetics, pharmacodynamics and safety of lansoprazole in infants with clinically-evident gastroesophageal reflux disease, Role: Investigator, TAP Pharmaceuticals, Inc,, (03/2005 - 03/2006) Status: Completed
Internal
- The efficacy of smoflipid on improving liver function in children with parenteral nutrition associated liver disease (PNALD), Role: Investigator, LLU Dept. of Nutrition, (07/2017 - 07/2018) Status: Completed
- Comparison of altered respiratory events (ARE) detection by transcutaneous respiratory rate monitoring (TCM), capnography and pulse-oximetry in pediatric patients undergoing esophagogastroduodenoscopy and colonoscopy under procedure related sedation, Role: PI, LLU Dept. of Pediatrics, (05/2015 - 05/2016) Status: Completed